1. Home
  2. ASH vs ZLAB Comparison

ASH vs ZLAB Comparison

Compare ASH & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ashland Inc.

ASH

Ashland Inc.

HOLD

Current Price

$73.33

Market Cap

3.1B

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$26.01

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASH
ZLAB
Founded
1924
2013
Country
United States
China
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
ASH
ZLAB
Price
$73.33
$26.01
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$65.57
$49.60
AVG Volume (30 Days)
597.1K
1.2M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
3.38%
N/A
EPS Growth
N/A
38.46
EPS
0.43
N/A
Revenue
$1,824,000,000.00
$460,156,000.00
Revenue This Year
$2.58
$9.75
Revenue Next Year
$4.28
$26.03
P/E Ratio
$171.95
N/A
Revenue Growth
N/A
15.33
52 Week Low
$46.30
$15.96
52 Week High
$78.25
$34.72

Technical Indicators

Market Signals
Indicator
ASH
ZLAB
Relative Strength Index (RSI) 61.03 67.26
Support Level $71.58 $16.98
Resistance Level $74.99 $27.08
Average True Range (ATR) 1.48 0.98
MACD -0.24 -0.00
Stochastic Oscillator 59.76 69.57

Price Performance

Historical Comparison
ASH
ZLAB

About ASH Ashland Inc.

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: